Literature DB >> 4981070

Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance.

S Silagi.   

Abstract

A clonally derived amelanotic melanoma cell line repeatedly has been forced to produce pigment by the inhibitor of DNA synthesis, I-beta-D-arabinofuranosylcytosine (ara-C) at sublethal levels. One ara-C-derived melanotic line has been cloned, and has continued to produce pigment for 2 years on normal medium. The inhibitor is most effective when administered to synchronized cells in four pulses on successive days at 1.8 x 10(-5)M during the S phase of the cell cycle. Colcemid at a sublethal concentration, and growth on medium solidified with agar also evoked pigment production in this line, but a large number of other inhibitors of biosynthetic processes did not, under the conditions tested. The melanotic lines are active producers of tyrosinase (DOPA oxidase), whereas the amelanotic line produces an inhibitor of tyrosinase activity. Both enzyme and inhibitor are labile at 4 degrees C and -20 degrees C, and decay of the inhibitor in homogenates of amelanotic cells reveals a low level of residual DOPA oxidase activity. The mean population doubling time of a cloned melanotic line is 23 hr, and that of a cloned amelanotic line 16.5 hr. A similar decrease in rate of growth is found in other melanotic lines and is believed to be a significant factor in maintaining this differentiated function. Rapid growth may be related to the production of an inhibitor by the amelanotic cells.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4981070      PMCID: PMC2107859          DOI: 10.1083/jcb.43.2.263

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  23 in total

1.  A turbidimetric assay for tyrosinase activity in frozen sections of mouse skin.

Authors:  M FOSTER; G S TREMBLY; T A STAMAS
Journal:  Proc Soc Exp Biol Med       Date:  1954-06

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Separation and characterization of multiple forms of tyrosinase from mouse melanoma.

Authors:  J B Burnett; H Seiler; I V Brown
Journal:  Cancer Res       Date:  1967-05       Impact factor: 12.701

4.  The action of arabinosylcytosine on synchronously growing populations of mammalian cells.

Authors:  R S Young; G A Fischer
Journal:  Biochem Biophys Res Commun       Date:  1968-07-11       Impact factor: 3.575

Review 5.  Introduction to the biochemistry of D-arabinosyl nucleosides.

Authors:  S S Cohen
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1966

6.  Synchronization of Chinese hamster cells by reversal of colcemid inhibition.

Authors:  E Stubblefield; R Klevecz
Journal:  Exp Cell Res       Date:  1965-12       Impact factor: 3.905

7.  Heritability of cellular differentiation: clonal growth and expression of differentiation in retinal pigment cells in vitro.

Authors:  R D Cahn; M B Cahn
Journal:  Proc Natl Acad Sci U S A       Date:  1966-01       Impact factor: 11.205

8.  Metabolism of 1-beta-D-arabinofuranosylcytosine in L cells.

Authors:  S Silagi
Journal:  Cancer Res       Date:  1965-10       Impact factor: 12.701

9.  Hybridization of a malignant melanoma cell line with L cells in vitro.

Authors:  S Silagi
Journal:  Cancer Res       Date:  1967-11       Impact factor: 12.701

10.  Differentiation in vitro: effects of Sephadex fractions of chick embryo extract.

Authors:  H G Coon; R D Cahn
Journal:  Science       Date:  1966-09-02       Impact factor: 47.728

View more
  23 in total

1.  Replication and differentiation in vitro of epidermal cells from normal human skin and from benign (psoriasis) and malignant (basal cell cancer) hyperplasia.

Authors:  B A Flaxman
Journal:  In Vitro       Date:  1972 Nov-Dec

2.  Modification of malignancy by 5-bromodeoxyuridine. Studies of reversibility and immunological effects.

Authors:  S Silagi
Journal:  In Vitro       Date:  1971 Sep-Oct

3.  Preparation of functional liposomes with peptide ligands and their binding to cell membranes.

Authors:  N Yagi; Y Ogawa; M Kodaka; T Okada; T Tomohiro; T Konakahara; H Okuno
Journal:  Lipids       Date:  2000-06       Impact factor: 1.880

4.  Some properties of Bomirski Ab amelanotic melanoma cells, which underwent spontaneous melanization in primary cell culture. Growth kinetics, cell morphology, melanin content and tumorigenicity.

Authors:  A Słomiński
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

5.  Tumorigenicity, immunogenicity, and virus production in mouse melanoma cells treated with 5-bromodeoxyuridine.

Authors:  S Silagi; D Beju; J Wrathall; E Deharven
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

6.  Peptidases released by necrotic cells control CD8+ T cell cross-priming.

Authors:  Jaba Gamrekelashvili; Tamar Kapanadze; Miaojun Han; Josef Wissing; Chi Ma; Lothar Jaensch; Michael P Manns; Todd Armstrong; Elizabeth Jaffee; Ayla O White; Deborah E Citrin; Firouzeh Korangy; Tim F Greten
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

7.  Histopathology and host response associated with reduced tumorigenicity of 5-bromodeoxyuridine--treated murine melanoma cells.

Authors:  K K Gyi; J R Wrathall
Journal:  Am J Pathol       Date:  1983-02       Impact factor: 4.307

8.  Melanogenesis in genetically determined pigment cell tumors of platyfish and platyfish-swordtail hybrids: correlation between tyrosine activity and degree of malignancy.

Authors:  U Vielkind; W Schlage; F Anders
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-12-15

9.  Characterization and cloning of p11, a transrepressor of Drosophila melanogaster retrotransposon 1731.

Authors:  J Lacoste; S Codani-Simonart; M Best-Belpomme; F Peronnet
Journal:  Nucleic Acids Res       Date:  1995-12-25       Impact factor: 16.971

Review 10.  The natural history of a family of transplantable melanomas in hamsters.

Authors:  A Bomirski; A Słominski; J Bigda
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.